Primary source: Inventurus Knowledge Solutions, NSE/BSE Regulation 30 disclosure, November 10, 2026
On November 10, 2026, Inventurus Knowledge Solutions completed the purchase of Turbo Health Holdings, LLC for USD 500,000 in cash. The buyer is IKS Inc., its U.S. wholly owned material subsidiary. The NSE filing says the target is a newly incorporated company in a segment of Optum Insight's ambulatory revenue cycle business, comprising certain transferred client contracts. The filing does not name a seller, and it does not say Optum announced a sale.
Cash, for 100% of Turbo Health Holdings, LLC. The IKS Inc. board approved the purchase on November 9, 2026, U.S. time. The acquisition was completed on November 10. The annexure says the company was incorporated on November 5, 2026.
The letter is a Regulation 30 disclosure to the National Stock Exchange of India and the BSE, dated November 10, 2026, from Inventurus Knowledge Solutions Limited (NSE: IKS, BSE: 544309). Sameer Chavan, company secretary, signed it. The annexure is the deal. The prose around it is the company's reason for doing it: an opportunity to expand market reach. That is a purpose sentence. It is not a client list.
| Item | What the November 10 disclosure states |
|---|---|
| Buyer | Inventurus Knowledge Solutions, Inc. (IKS Inc.), a U.S. company and a wholly owned material subsidiary of the listed Indian parent. The board of IKS Inc. approved the purchase on November 9, 2026, U.S. time. |
| Target | Turbo Health Holdings, LLC, incorporated in the United States. The annexure says the date of incorporation is November 5, 2026. Turnover for the last three years is "Not Applicable as the Target is newly incorporated." |
| What was bought | 100% of the shareholding. Completed November 10, 2026, after IKS Inc. executed the agreements. |
| Price | Cash consideration of USD 500,000. The same figure is repeated as the cost of acquisition. No shares, no earnout, no other consideration is listed. |
| The book, in the filing's words | "Engaged in Healthcare technology, the Target is a newly incorporated entity, in a segment of the ambulatory revenue cycle management (RCM) business of Optum Insight, comprising certain transferred client contracts." The background line is shorter: "Newly incorporated entity where certain client contracts have been transferred." |
| Industry line | "Healthcare technology and IT services / software industry." Country of presence: United States. |
| Related party | "No, the acquisition does not constitute a related party transaction." The promoter and promoter group "does not have any interest in the entity being acquired." |
| Approvals | Governmental or regulatory approvals required: "None." |
| Seller | Not named. The filing does not identify who transferred the contracts or who sold the shares. |
It is not a disclosed value for Optum Insight's ambulatory RCM business. The filing describes certain transferred client contracts inside a segment of that business. It does not give a contract count, a client name, a fee, or revenue. There is nothing in the document to turn into a multiple, and this article does not invent one.
This is RevCycleAI's read. The asset, on the filing's own description, is the contracts. A half-million-dollar close for a company incorporated on November 5 is a vehicle transaction. The work that matters to a billing director is whose name is on those contracts on Monday, and who sends the next statement.
IKS already made the large U.S. move this year. RevCycleAI's July coverage put the completed TruBridge acquisition at July 9, 2026, and the price at $557 million, the figure Becker's reported. That was a public rural health-IT company, bought outright and left as a wholly owned subsidiary. Turbo Health is not that deal. The dollars are not in the same league, and the filing does not describe an EHR, a hospital book, or a platform. It describes transferred ambulatory client contracts sitting in a new LLC.
If you are on an Optum Insight ambulatory contract, read the adjective. "Certain" is doing all the work. The disclosure is to Indian exchanges, not a letter to the practices. It does not say your agreement moved. It says some agreements, from a segment of that business, were transferred into the entity IKS now owns. A transition notice is the document that would name you. This filing is not that notice.
The same morning, Google Cloud launched Gemini for healthcare and named Optum as a launch customer, with Optum eligibility connectors still in limited testing. That is a product story. It is not evidence that Optum sold a business line, and the IKS filing does not cite it.
IKS paid USD 500,000 cash for 100% of Turbo Health Holdings, a U.S. LLC incorporated November 5 and acquired November 10. The filing's description of the asset is certain client contracts from a segment of Optum Insight's ambulatory RCM business. The filing does not name a seller, and it is not an Optum announcement.
Count the contracts, not the headline. A completed change of control, all cash, no regulatory approval, not a related-party deal: that part of the paper is clean. The operating part is still blank. No client, no fee, no revenue, and a target the company itself marks as having no historical turnover.
The open item is the list. Until a client name or a dollar of contract revenue shows up in a later filing or a notice to the practices, USD 500,000 is the price of the shares, and nothing larger.
Price, what transferred, and what the document leaves out.
Sources: Inventurus Knowledge Solutions Limited, Regulation 30 disclosure to NSE and BSE, "Acquisition of Turbo Health Holdings, LLC," November 10, 2026, including Annexure I. The incorporation date, November 5, 2026, is item 10(iii) of that annexure. ScanX, November 10, 2026, also states the November 5 incorporation date. ScanX's comment on what the price "likely" represents is not used. The TruBridge date and $557 million are as stated in RevCycleAI's July 10, 2026 article, which attributes the dollar figure to Becker's. No contract count, client name, or target revenue was disclosed, and none is estimated. Optum is not named in the filing as the seller.